Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (โOSAโ) and snoring in adults, today announced that it plans to release financial results for the third quarter ended Sept. 30, 2021, after market close on Monday, Nov. 15, 2021. Vivos will host a conference call the same day at 5:00 p.m. Eastern Time to review the results and provide an overview of the companyโs recent milestones and growth strategy. Interested parties may access a live webcast via the Vivosโ website and join the conference call by dialing (888) 394-8218 or (720) 452-9217 (international) and entering passcode 5806322. A replay and online archive of the webcast will be available shortly after the call.
To view the full press release, visit https://ibn.fm/GpgGb
About Vivos Therapeutics Inc.
Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for adult patients suffering from mild to moderate obstructive sleep apnea (โOSAโ). The Vivos treatment involves a customized oral appliance and protocols called the Vivos System. Vivos believes that its Vivos System oral appliance technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos also sells orthodontic appliances for adults and children. Vivosโ oral appliances have proven effective in over 19,000 patients worldwide by more than 1,250 trained dentists. Combining proprietary technologies and protocols that alter the size, shape and position of the tissues of a patientโs upper airway, the Vivos System opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes VivosScore, powered by the SleepImage diagnostic technology for home sleep testing in adults and children. The Vivos Integrated Practice (โVIPโ) program offers dentists training and other value-added services in connection with using the Vivos System. For more information, visit www.VivosLife.com.
NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the companyโs newsroom at http://ibn.fm/VVOS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products youโll need to ensure that your next press release grabs the attention of your target audience and doesnโt let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offerย UNLIMITED Wordsย on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentaryย Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of theย 50+ brandsย that make up theย InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. Itโs unlike anything youโve seen before.
For more information, please visitย https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:ย http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of theย InvestorBrandNetwork.
